INTERLEUKIN-12 AS A POTENTIAL TARGET FOR THE TREATMENT OF MYASTHENIA GRAVIS
- 2 Anni 1997/1999
- 51.646€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 1998 EUROPEAN JOURNAL OF IMMUNOLOGY
IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease